At EnClear Therapies, we are combining Bioscience & Med-tech expertise to develop solutions that improve and extend the lives of patients with CNS disease. The team at EnClear is developing systems and medical interventions that Access, Recirculate & Modify CSF for: › Targeted removal of toxicity from CSF correlated to neurodegenerative disease progression. › Continuous localized delivery of therapeutics & monitoring of CSF to ensure effective and personalized therapy.
View Top Employees from EnClear TherapiesWebsite | http://www.encleartherapies.com |
Employees | 12 (8 on RocketReach) |
Founded | 2018 |
Address | 65 Park St 3, Newburyport, Massachusetts 01950, US |
Technologies |
JavaScript,
HTML,
Twitter
+7 more
(view full list)
|
Industry | Medical Devices, Biotechnology, Science and Engineering, Therapeutics, Health Care |
Looking for a particular EnClear Therapies employee's phone or email?
Douglas Hicks is the Chief Business Officer of EnClear Therapies.
8 people are employed at EnClear Therapies.
EnClear Therapies is based in Newburyport, Massachusetts.